{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:04:42Z","timestamp":1790316282510,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007414","name":"Qassim University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007615","name":"University of Dammam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Biological Sciences"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.sjbs.2021.04.057","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T02:52:43Z","timestamp":1619578363000},"page":"4560-4568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies"],"prefix":"10.1016","volume":"28","author":[{"given":"Qazi Mohammad Sajid","family":"Jamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varish","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Azam","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A","family":"Alzohairy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1491-6402","authenticated-orcid":false,"given":"Ahmad","family":"Almatroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4532-9128","authenticated-orcid":false,"given":"Saad","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad N.","family":"Alomary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"AlYahya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashwa Talaat","family":"Shesha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3087-852X","authenticated-orcid":false,"given":"Suriya","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sjbs.2021.04.057_b0005","article-title":"A Molecular docking study against COVID-19 protease with a pomegranate phyto-constituents 'urolithin' and other repurposing drugs: from a supplement to ailment","volume":"51\u201362","author":"Ahmad","year":"2020","journal-title":"J. Pharm. Res. Int."},{"key":"10.1016\/j.sjbs.2021.04.057_b0010","doi-asserted-by":"crossref","unstructured":"Al-Bari, M.A.A., 2017 Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol Res Perspect 5(1), e00293. Published 2017 Jan 23. doi:10.1002\/prp2.293.","DOI":"10.1002\/prp2.293"},{"issue":"2","key":"10.1016\/j.sjbs.2021.04.057_b0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3390\/medicina57020169","article-title":"Natural products and nutrients against different viral diseases: prospects in prevention and treatment of SARS-CoV-2","volume":"57","author":"Ali","year":"2021","journal-title":"Medicina"},{"issue":"12","key":"10.1016\/j.sjbs.2021.04.057_b0020","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1080\/17425247.2020.1813712","article-title":"Lipid-based nano delivery of Tat-peptide conjugated drug or vaccine\u2013promising therapeutic strategy for SARS-CoV-2 treatment","volume":"17","author":"Ansari","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"11","key":"10.1016\/j.sjbs.2021.04.057_b0025","doi-asserted-by":"crossref","first-page":"8069","DOI":"10.1016\/j.arabjc.2020.09.037","article-title":"TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): potential therapeutic intervention to combat COVID-19","volume":"13","author":"Ansari","year":"2020","journal-title":"Arabian J. Chem."},{"key":"10.1016\/j.sjbs.2021.04.057_b0030","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.sjbs.2021.04.057_b0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.sjbs.2021.04.057_b0040","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program","volume":"30","author":"Brooks","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.sjbs.2021.04.057_b0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","article-title":"Structure analysis of the receptor binding of 2019-nCoV [published online ahead of print, 2020 Feb 17]","volume":"525","author":"Chen","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.sjbs.2021.04.057_b0050","unstructured":"Coronavirus disease 2019. https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019 Accessed: 2021-04-09."},{"key":"10.1016\/j.sjbs.2021.04.057_b0055","series-title":"Discovery Studio Visualizer], [Software version 2020","author":"Dassault Syst\u00e8mes BIOVIA","year":"2020"},{"key":"10.1016\/j.sjbs.2021.04.057_b0060","doi-asserted-by":"crossref","unstructured":"Ferreira, L.G., Dos Santos, R.N., Oliva, G., Andricopulo, A.D., 2015. Molecular docking and structure-based drug design strategies. Molecules. 2015;20(7):13384\u201013421. Published Jul 22. doi:10.3390\/molecules200713384.","DOI":"10.3390\/molecules200713384"},{"key":"10.1016\/j.sjbs.2021.04.057_b0065","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [published online ahead of print, 2020 Mar 20]","volume":"105949","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.sjbs.2021.04.057_b0070","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3390\/molecules26041191","article-title":"Therapeutic intervention of COVID-19 by natural products: a population-specific survey directed approach","volume":"26","author":"Gomez","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.sjbs.2021.04.057_b0075","doi-asserted-by":"crossref","first-page":"20288","DOI":"10.1039\/D0RA01773F","article-title":"Estimation of a stronger heparin binding locus in fibronectin domain III14 using thermodynamics and molecular dynamics","volume":"10","author":"Gupta","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.sjbs.2021.04.057_b0080","doi-asserted-by":"crossref","first-page":"526","DOI":"10.6026\/97320630010526","article-title":"Molecular Docking of Known Carcinogen 4-(Methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) with Cyclin Dependent Kinases towards Its Potential Role in Cell Cycle Perturbation","volume":"10","author":"Haneef","year":"2014","journal-title":"Bioinformation"},{"key":"10.1016\/j.sjbs.2021.04.057_b0085","doi-asserted-by":"crossref","unstructured":"Huang, Y., Yang, C., Xu, X.-feng, Xu, W., Liu, S.-wen, 2020. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacologica Sinica 41, 1141\u20131149. doi:10.1038\/s41401-020-0485-4.","DOI":"10.1038\/s41401-020-0485-4"},{"key":"10.1016\/j.sjbs.2021.04.057_b0090","doi-asserted-by":"crossref","unstructured":"Jamal QMS. (2020). Structural Recognition and Binding Pattern Analysis of Human Topoisomerase II Alpha with Steroidal Drugs: In Silico Study to Switchover the Cancer Treatment.Asian Pacific J. Cancer Prevent.: APJCP, 21(5), 1349\u20131355. https:\/\/doi.org\/10.31557\/APJCP.2020.21.5.1349.","DOI":"10.31557\/APJCP.2020.21.5.1349"},{"key":"10.1016\/j.sjbs.2021.04.057_b0095","article-title":"Identification of doxorubicin as a potential therapeutic against SARS-CoV-2 (COVID-19) protease: a molecular docking and dynamics simulation studies","volume":"1\u201315","author":"Jamal","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"22B","key":"10.1016\/j.sjbs.2021.04.057_bib216","doi-asserted-by":"crossref","first-page":"12","DOI":"10.9734\/jpri\/2021\/v33i22B31394","article-title":"Smoking May Increase the Risk of COVID-19 Infection: Evidence from In Silico Analysis","volume":"33","author":"Jamal","year":"2021","journal-title":"J. Pharmaceutical Res.Int."},{"issue":"886","key":"10.1016\/j.sjbs.2021.04.057_b0100","doi-asserted-by":"crossref","first-page":"173447","DOI":"10.1016\/j.ejphar.2020.173447","article-title":"Coronavirus diseases 2019: current biological situation and potential therapeutic perspective","volume":"5","author":"Khan","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.sjbs.2021.04.057_b0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-61779-588-6_10","article-title":"Methods of protein structure comparison","volume":"857","author":"Kufareva","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.sjbs.2021.04.057_b0110","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bpj.2009.11.011","article-title":"Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors","volume":"98","author":"Kuzmanic","year":"2010","journal-title":"Biophys. J."},{"key":"10.1016\/j.sjbs.2021.04.057_b0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.sjbs.2021.04.057_b0120","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.sjbs.2021.04.057_b0125","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.sjbs.2021.04.057_b0130","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"issue":"16","key":"10.1016\/j.sjbs.2021.04.057_b0135","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"3","key":"10.1016\/j.sjbs.2021.04.057_b0140","first-page":"185","article-title":"The molecular docking study of potential drug candidates showing anti-COVID-19 activity by exploring of therapeutic targets of SARS-CoV-2","volume":"4","author":"Narkhede","year":"2020","journal-title":"Eurasian J. Med. Oncol."},{"key":"10.1016\/j.sjbs.2021.04.057_b0145","doi-asserted-by":"crossref","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminf."},{"issue":"10256","key":"10.1016\/j.sjbs.2021.04.057_bib217","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(20)31863-8","article-title":"Azithromycin for severe COVID-19","volume":"396","author":"Oldenburg","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.sjbs.2021.04.057_b0150","article-title":"Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: anin silicostudy for drug development","volume":"1\u201311","author":"Pandey","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.sjbs.2021.04.057_b0155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/ijp.IJP_115_20","article-title":"Drug targets for corona virus: a systematic review","volume":"52","author":"Prajapat","year":"2020","journal-title":"Indian J Pharmacol."},{"issue":"10","key":"10.1016\/j.sjbs.2021.04.057_b0160","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.sjbs.2020.05.024","article-title":"Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response","volume":"27","author":"Rehman","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.sjbs.2021.04.057_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2020.08.003","article-title":"Syndrome resembling Kawasaki disease in COVID-19 asymptomatic children","author":"Rehman","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.sjbs.2021.04.057_b0170","doi-asserted-by":"crossref","first-page":"173720","DOI":"10.1016\/j.ejphar.2020.173720","article-title":"Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19","volume":"890","author":"Toor","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.sjbs.2021.04.057_b0175","unstructured":"Turner, P., 2005. XMGRACE, Version 5.1. 19. Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology, Beaverton, OR."},{"issue":"16","key":"10.1016\/j.sjbs.2021.04.057_b0180","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"issue":"2","key":"10.1016\/j.sjbs.2021.04.057_b0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.sjbs.2021.04.057_b0190","doi-asserted-by":"crossref","first-page":"e00127","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol."},{"key":"10.1016\/j.sjbs.2021.04.057_b0195","doi-asserted-by":"crossref","unstructured":"Wang, C., Horby, P.W., Hayden, F.G., Gao, G.F., 2020. A novel coronavirus outbreak of global health concern [published correction appears in Lancet. 2020 Jan 29;:].Lancet 395(10223):470\u2010473. doi:10.1016\/S0140-6736(20)30185-9.","DOI":"10.1016\/S0140-6736(20)30185-9"},{"key":"10.1016\/j.sjbs.2021.04.057_b0200","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.sjbs.2021.04.057_b0205","doi-asserted-by":"crossref","unstructured":"Yao, X., Ye, F., Zhang, M., et al., 2020. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [published online ahead of print, 2020 Mar 9]. Clin Infect Dis ciaa237. doi:10.1093\/cid\/ciaa237.","DOI":"10.1093\/cid\/ciaa237"},{"issue":"7798","key":"10.1016\/j.sjbs.2021.04.057_b0210","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.sjbs.2021.04.057_b0215","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/jcc.21816","article-title":"SwissParam: a fast force field generation tool for small organic molecules","volume":"32","author":"Zoete","year":"2011","journal-title":"J. Comput. Chem."}],"container-title":["Saudi Journal of Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X21003181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X21003181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:12:59Z","timestamp":1761153179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319562X21003181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1319562X21003181"],"URL":"https:\/\/doi.org\/10.1016\/j.sjbs.2021.04.057","relation":{},"ISSN":["1319-562X"],"issn-type":[{"value":"1319-562X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic development by repurposing drugs targeting SARS-CoV-2 spike protein interactions by simulation studies","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Biological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjbs.2021.04.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}